The indications for Gadobutrol injection, a generic substitute for Gadavist, include neurovascular and cardiovascular assessments as well as breast malignancy detection with magnetic resonance imaging (MRI).
Fresenius Kabi has launched Gadobutrol Injection, a generic contrast alternative to Gadavist, for use in magnetic resonance imaging (MRI).
A high relaxivity macrocyclic agent, Gadobutrol Injection offers a range of MRI indications including:
• detection and assessment of malignant breast disease in adults;
• diagnosis and evaluation of supra-aortic or renal artery disease in adults and pediatric patients, including term neonates;
• detection of a disrupted blood brain barrier and/or abnormal vascularity in patients of all ages, including term neonates; and
• assessment of myocardial perfusion and late gadolinium enhancement in patients with suspected or known coronary artery disease (CAD).
“Fresenius Kabi is pleased to introduce Gadobutrol Injection as the newest addition to our (United States) radiology portfolio, expanding the range of cost-effective contrast agent options available to hospitals and clinics,” noted John Ducker, the president and CEO of Fresenius Kabi USA.
The company said Gadobutrol Injection is available in single dose vials at 2, 7.5, 10 and 15 mL
(Editor’s note: For related content, see “MRI Study: Half-Dose Gadopiclenol Offers Similar Visualization and Safety as Full-Dose Gadobutrol.”)
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
July 22nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Stroke MRI Study Assesses Impact of Motion Artifacts Upon AI and Radiologist Lesion Detection
July 16th 2025Noting a 7.4 percent incidence of motion artifacts on brain MRI scans for suspected stroke patients, the authors of a new study found that motion artifacts can reduce radiologist and AI accuracy for detecting hemorrhagic lesions.